Shoulder
Reverse shoulder arthroplasty versus hemiarthroplasty for acute proximal humeral fractures. A blinded, randomized, controlled, prospective study

https://doi.org/10.1016/j.jse.2014.06.035Get rights and content

Background

There is no consensus on what type of arthroplasty is best for the treatment of complex proximal humeral fractures in elderly patients. The purpose of this prospective study was to compare the outcomes of reverse shoulder arthroplasty (RSA) and hemiarthroplasty (HA).

Methods

Sixty-two patients older than 70 years were randomized to RSA (31 patients) and HA (31 patients). One HA patient died at 1 year, and she was excluded. The mean follow-up was 28.5 months (range, 24-49 months).

Results

Compared with HA patients, RSA patients had significantly higher (P = .001) mean University of California–Los Angeles (29.1 vs 21.1) and Constant (56.1 vs 40.0) scores, forward elevation (120.3° vs 79.8°), and abduction (112.9° vs 78.7°) but no difference in internal rotation (2.7° vs 2.6°; P = .91). The Disabilities of the Arm, Shoulder, and Hand score was higher in the HA patients (17 vs 29; P = .001). In the HA group, 56.6% of tuberosities healed and 30% resorbed. Patients with failure of tuberosities had significantly worse functional outcomes. There were 2 complications (intraoperative humeral fracture and superficial infection). One patient was manipulated under general anesthesia because of postoperative stiffness. Six patients with HA had proximal migration that required revision to RSA. In the RSA group, 64.5% of tuberosities healed and 13.2% resorbed. Functional outcome was irrespective of healing of the tuberosities. Notching was observed in only 1 RSA patient. One patient developed a hematoma and another a deep infection requiring a 2-stage revision to another RSA.

Conclusion

RSA resulted in better pain and function and lower revision rate. Revision from HA to RSA does not appear to improve outcomes.

Section snippets

Materials and methods

A blinded, randomized, controlled prospective study was designed to compare the outcomes between RSA and HA in elderly patients with acute complex proximal humeral fractures. The study was considered blinded because the surgeons were not involved in the randomization process, and the clinical and radiologic evaluations were performed by independent observers who had not participated in the surgeries.

Baseline information

Between 2009 and 2011, 62 consecutive patients were included for study. They were allocated to treatment with RSA (31 patients) or HA (31 patients). The mechanism of injury in all patients was a fall on the upper extremity. Before fracture, normal function of the shoulder was reported in all but 1 patient in the HA group and 2 patients in the RSA group. All but 1 patient completed the minimum follow-up of 2 years. In the HA group, 1 patient died at 1 year postoperatively for reasons not related

Discussion

HA has commonly been recommended as the treatment of choice for complex proximal humeral fractures in the elderly when internal fixation is not an option,1 but recent studies have reported inconsistent results with HA.13, 18, 27 The functional outcome largely depends on the anatomic healing of the tuberosities,4 but this healing is difficult in most elderly patients with comminuted fractures.2 RSA has been proposed as an alternative treatment for these acute complex fractures7, 11 on the basis

Conclusions

The findings of this study indicated that RSA was superior to HA with respect to pain, functional outcome, and revision rate. Revision from HA to RSA does not appear to improve outcomes. Our study confirms the place of RSA in patients older than 70 years with complex proximal humeral fractures. Although short-term results with RSA are promising, more long-term prospective studies are necessary. In addition, our results could not be extrapolated to other designs of RSAs.

Disclaimer

The authors, their immediate families, and any research foundation with which they are affiliated have not received any financial payments or other benefits from any commercial entity related to the subject of this article.

References (36)

Cited by (258)

View all citing articles on Scopus

This study was approved by the Comité Ético de Investigación Clínica (CEIC), Hospital Universitario de Elda (study reference number: PI2009-11), and informed consent was obtained.

View full text